From a genetic innovation to mass health programmes: The diffusion of Down's Syndrome prenatal screening and diagnostic techniques in France

Social Science and Medicine

Volumn 63, Issue 8, 2006, Pages 2041-2051

  Vassy, Carine ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Biomedical innovations; Down's syndrome; France; Genetics; Prenatal screening

Indexed keywords

ABNORMALITY; ABORTION; BIOCHEMISTRY; CHROMOSOME; GENETICS; HEALTH CARE; HEALTH EDUCATION; HEALTH RISK; INNOVATION;

ARTICLE; DECISION MAKING; DIAGNOSTIC TEST; DOWN SYNDROME; ECHOGRAPHY; FRANCE; HEALTH PROGRAM; HUMAN; MEDICAL ETHICS; POLITICS; PUBLIC FIGURE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT;

ABORTION, EUGENIC; DIFFUSION OF INNOVATION; DOWN SYNDROME; FEMALE; FRANCE; GENETIC COUNSELING; GENETIC SCREENING; GENETIC TESTING; HUMANS; INFORMED CONSENT; INTERVIEWS; INTERVIEWS AS TOPIC; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EURASIA; EUROPE; FRANCE; WESTERN EUROPE;

EID: 33747783194     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2006.04.032     Document Type: Article

References (62)

1. Alderson P. Prenatal screening, ethics and Down's syndrome: A literature review. Nursing Ethics 8 4 (2001) 360-374
2. Beauchamp T., and Childress J. Principles of biomedical ethics (2001), Oxford University Press, Oxford
3. Becker H. Outsiders (1963), Free Press of Glencoe, Macmillan
4. Boissonnat V. Fausses évidences et vrais dilemmes en santé publique: Le dépistage radiologique du cancer du sein. Santé Publique 16 1 (2004) 9-20
5. Bourret P., and Huard P. Création, appropriation, recomposition: Processus innovants dans la production du diagnostic prénatal. Sciences sociales et santé 8 4 (1990) 57-89
6. Briard, M.L. (2003). Organisation du diagnostic prénatal en France: cadre législatif, encadrement règlementaire et financier. In Dommergues, P., Aymé, S., Janiaud, P., & Séror, V. (2003) op. cit.
7. Burne, J. (2003). More than you need to know ?. The Guardian, November 15th, http://www.guardian.co.uk/weekend/story/0,3605,1084090,00.html.
8. Cadoré B., and Boitte P. Questions éthiques à propos de l"indication du triple test dans la démarche de dépistage anténatal de la trisomie 21. Journal International de Bioéthique 9 1 (1998) 157-168
9. Carles E., and Eydoux P. Cytogénétique prénatale: Bilan 1999 pour l'association des cytogénéticiens de langue française. Médecine Fœtale et Echographie en Gynécologie 50 (2002) 5-8
10. Chambliss D. Is bioethics irrelevant?. Contemporary Sociology 22 5 (1993) 649-652
11. Comité Consultatif National d'Ethique, (1993). Avis sur le dépistage du risque de la trisomie 21 foetale. Paris, Rapport du 22 juin 1993, Circulaire 37.
12. Croquette M.F., Delobel B., and Chantepie S. La cytogénétique prénatale: Quel crédit accorder à un caryotype dit normal en 1998?. Médecine de l'homme 240 (1999) 13-18
13. Crozier M., and Friedberg E. Actors and systems: The politics of collective action (1981), University of Chicago Press, Chicago
14. In: David D., and Gosme-Séguret S. (Eds). Le diagnostic prenatal: Aspects psychologiques (1996), ESF Edition, Paris
15. De Vigan C., Vodovar V., Goujard J., Garel M., Vayssière C., and Goffinet F. Mothers' knowledge of screening for trisomy 21 in 1999: A survey in Paris maternity units. European Journal of Obstetrics and Gynecology 104 1 (2002) 14-20
16. In: De Vries R., Benoit C., Van Teijlingen E., and Wrede S. (Eds). Birth by design: Pregnancy, maternity care, and midwifery in North America and Europe (2001), Routledge, New York
17. De Vries R., and Conrad P. Why bioethics needs sociology. In: DeVries R., and Subedi J. (Eds). Bioethics and society: Constructing the ethical enterprise (1998), Prentice-Hall, Englewood Cliffs, NJ
18. Dommergues P., Aymé S., Janiaud P., and Séror V. Diagnostic prénatal: Pratiques et enjeux (2003), Editions INSERM, Paris
19. Dusart A. La détection des anomalies fœtales: Analyse sociologique (1995), Editions du CTNERHI, Paris
20. Etchegoyen. La valse des éthiques (1991), François Bourin, Paris
21. Fairgrieve S., Magnay D., White I., and Burn J. Maternal serum screening for Down's syndrome: A survey of midwives' views. Public Health 111 (1997) 383-385
22. Farrant W. Who's for amniocentesis?. The politics of prenatal screening. In: Homans H. (Ed). The sexual politics of reproduction (1985), Gower, Aldershot
23. Fellous M. Echographie, fœtus, personne. In: Novaes S. (Ed). Biomédecine et devenir de la personne (1991), Seuil, Paris
24. Fox R. The sociology of medicine: A participant observer's view (1989), Prentice-Hall, Englewood Cliffs, NJ
25. Gaudillière J.P. Inventer la biomédecine (2002), La Découverte, Paris
26. Goujard, J. (2002). Diagnostic prénatal: mise à jour concernant Trisomie 21, Spina bifida et cardiopathies congénitales. Synthèse pour le Comité National Français des Registres, unpublished paper.
27. Green J. Serum screening for Down's syndrome: Experience of obstetricians in England and Wales. British Medical Journal 309 (1994) 769-772
28. Heyman B., and Henriksen M. Risk, age and pregnancy: A case study of prenatal genetic screening and testing (2001), Palgrave, Basingstoke
29. Katz Rothman B. The tentative pregnancy: Amniocentesis and the sexual politics of motherhood (1988), Pandora, London
30. Katz Rothman B. Spoiling the pregnancy: Prenatal diagnosis in the Netherlands. In: De Vries R., Benoit C., Van Teijlingen E., and Wrede S. (Eds). Birth by design: Pregnancy, maternity care, and midwifery in North America and Europe (2001), Routledge, New York
31. Leach M., Scoones I., and Thompson L. Citizenship, science and risk: Conceptualizing relationships across issues and settings. IDS Bulletin 33 2 (2002) 40-48
32. Lhermitte M.A. Le contentieux de la naissance d'enfants handicapés. La Gazette du palais (1997) (25 octobre, 77)
33. Mansfield C., Hopfer S., and Marteau T. Termination rates after prenatal diagnosis of Down's Syndrome, Spina Bifida, Anencephaly, and Turner and Klinefelter Syndromes: A systematic literature review. Prenatal diagnosis 19 (1999) 808-812
34. Marteau T.M., Slack J., Kidd J., and Shaw R.W. Presenting a routine screening test in antenatal care: Practice observed. Public Health 106 2 (1992) 131-141
35. Mattei, J. F. (1996). Le dépistage de la trisomie 21 à l'aide des marqueurs sériques maternels. Paris, Rapport de la mission confiée par M. J. Barrot, Ministre du Travail et des Affaires Sociales et M. H. Gaymard, Secrétaire d'Etat à la Santé, au Professeur Mattei.
36. Mattei J.F. Le diagnostic prénatal (2000), Flammarion, Paris
37. Memmi D. Les gardiens du corps: Dix ans de magistère bioéthique (1996), Editions de l'Ecole des Hautes Etudes en Sciences Sociales, Paris
38. Moatti J.P., Le Galès C., Julian C., Durbec J.P., Mattei J.F., and Aymé S. Socio-cultural inequities in access to prenatal diagnosis: The role of insurance coverage and regulatory policies. Prenatal Diagnosis 10 (1990) 313-325
39. Moyse D. Le risque de naître différent. Esprit 259 (1999) 65-74
40. Muller P. Les politiques publiques (1990), Presses Universitaires de France, Paris
41. Nisand I. Vers la réification de l'être humain ?. Le Monde (2001) (12 July, 11)
42. Oakley A. Essays on women, medicine and health (1993), Edinburgh University Press, Edinburgh
43. Penrose L. The relative effect of paternal and maternal age in mongolism. Journal of Genetics 27 (1933) 219
44. Pilnick A. Genetics and society (2002), Open University Press, Buckingham
45. Press N., and Browner C.H. Why women say yes to prenatal diagnosis. Social Science & Medicine 45 7 (1997) 979-989
46. Rapp R. Testing women, testing the foetus (2000), Routledge, New York
47. Rayner S. Democracy in the age of assessment: Reflections on the roles of expertise and democracy in public-sector decision making. Science and Public Policy 30 3 (2003) 163-170
48. Reid M. The diffusion of four prenatal screening tests across Europe (1991), King's Fund Centre, London
49. Roqueplo P.H. Entre savoir et décision, l'expertise scientifique (1997), INRA Editions, Paris
50. Schwartz-Cowan R. Aspects of the history of the prenatal diagnosis. Fetal Diagnosis and Therapy 8 S1 (1993) 10-17
51. Shakespeare T. Choices and rights: Eugenics, genetics and disability equality. Disability and Society 13 5 (1998) 665-681
52. Shakespeare T. Losing the plot? Medical and activist discourses of the contemporary genetics and disability. In: Conrad P., and Gabe J. (Eds). Sociological perspectives on the new genetics (1999), Blackwell, Oxford
53. Simon-Bouy B. Les marqueurs de la trisomie 21. Contraception, Fertilité, Sexualité 27 (1999) 589-591
54. Smith D., Shaw R., and Marteau T. Informed consent to undergo serum screening for Down's syndrome: The gap between policy and practice. British Medical Journal 309 (1994) 776
55. Steffen M. Genèse et conduite des politiques sociales. In: Aymé S., Henrard J.C., Colvez A., Ravaud J.F., Sabouraud O., and Triomphe A. (Eds). Handicap et vieillissement: Politiques publiques et pratiques sociales (1996), INSERM, Paris
56. Stocking B. Factors affecting the diffusion of three kinds of innovative medical technology in European Community Countries and Sweden. In: Reid M. (Ed). The diffusion of four prenatal screening tests across Europe (1991), King's Fund Centre, London
57. Testart J. Les hommes probables: De la procréation aléatoire à la reproduction normative (1999), Seuil, Paris
58. Thornton J. Should health screening be private? (1999), IEA Health & Welfare Unit, London
59. Vailly J. Une politique de santé 'a priori': Le dépistage néonatal de la mucoviscidose en Bretagne. Sciences Sociales et Santé 22 4 (2004) 35-60
60. Vallée J. Quelles limites au dépistage de la trisomie 21?. La Revue Prescrire 22 226 (2002) 235
61. Vassy C. How prenatal diagnosis became acceptable in France. Trends in Biotechnology 23 5 (2005) 246-249
62. Wald N., Kennard A., Densem J.W., Cuckle H., Chard T., and Butler L. Antenatal maternal screening for Down's Syndrome: Results of a demonstration project. British Medical Journal 305 (1992) 391-394